FibroGen (NASDAQ:FGEN) Earnings Information
FibroGen last posted its quarterly earnings data on November 5th, 2020. The biopharmaceutical company reported $0.35 earnings per share for the quarter, beating analysts' consensus estimates of ($0.80) by $1.15. The company had revenue of $44.03 million for the quarter, compared to analysts' expectations of $61.49 million. Its quarterly revenue was up 32.7% on a year-over-year basis. FibroGen has generated ($0.89) earnings per share over the last year. FibroGen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 1st, 2021 based off prior year's report dates.
FibroGen Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
FibroGen (NASDAQ:FGEN) Earnings Estimates
2021 EPS Consensus Estimate: ($0.83)
FibroGen (NASDAQ FGEN) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)